153 related articles for article (PubMed ID: 24969595)
1. [Expression of programmed death-1 and programmed death ligand-1 in the peripheral T-lymphocytes from patients with chronic periodontitis].
Zhu D; Liu F; Dai F; Luo X; Hong B
Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Apr; 49(4):216-9. PubMed ID: 24969595
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory signals mediated by programmed death-1 are involved with T-cell function in chronic periodontitis.
Figueira EA; de Rezende ML; Torres SA; Garlet GP; Lara VS; Santos CF; Avila-Campos MJ; da Silva JS; Campanelli AP
J Periodontol; 2009 Nov; 80(11):1833-44. PubMed ID: 19905953
[TBL] [Abstract][Full Text] [Related]
3. [Effects of soluble programmed death ligand 1 on regulating the proliferation of T lymphocytes and its mechanism].
Zhao J; Pan X; Xing Y; Lu M; Chen Y; Shi M
Zhonghua Yi Xue Za Zhi; 2015 Feb; 95(6):449-52. PubMed ID: 25916783
[TBL] [Abstract][Full Text] [Related]
4. Menopausal status influences the expression of programmed death (PD)-1 and its ligand PD-L1 on immune cells from the human female reproductive tract.
Shen Z; Rodriguez-Garcia M; Patel MV; Barr FD; Wira CR
Am J Reprod Immunol; 2016 Aug; 76(2):118-25. PubMed ID: 27321759
[TBL] [Abstract][Full Text] [Related]
5. [Expression of PD-1 and PD-L1 in the peripheral blood of advanced non-small-cell lung cancer patients and its implications].
Xing YF; Pan X; Qian B; Shi MH
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):111-114. PubMed ID: 30669748
[No Abstract] [Full Text] [Related]
6. [Effect of antiviral treatment on expression of programmed death 1 and programmed death ligand 1 on peripheral T lymphocytes in patients with chronic hepatitis C].
Cai RT; Shen L; Zhao W; Yang YF; Zhang YC
Zhonghua Gan Zang Bing Za Zhi; 2013 Apr; 21(4):261-6. PubMed ID: 24021786
[TBL] [Abstract][Full Text] [Related]
7. Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer.
Zhang J; Zhang H; Luo Y
Med Sci Monit; 2019 Feb; 25():1275-1282. PubMed ID: 30771277
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Yoshida S; Ishibashi Y; Haraguchi T; Shiba N; Ohshima K
Clin Exp Med; 2018 Nov; 18(4):487-494. PubMed ID: 29961175
[TBL] [Abstract][Full Text] [Related]
9. Decreased PD-1 expression on circulating CD4
Cai L; Zhang C; Wu J; Zhou W; Chen T
Joint Bone Spine; 2019 Jan; 86(1):61-68. PubMed ID: 29609005
[TBL] [Abstract][Full Text] [Related]
10. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.
Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R
Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680
[TBL] [Abstract][Full Text] [Related]
11. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus].
Luo L; Shu M; Li S; Cai Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624
[TBL] [Abstract][Full Text] [Related]
12. [Levels of programmed death-1 and programmed death ligand-1 in the peripheral blood of patients with oral squamous cell carcinoma and its clinical implications].
Zhang P; Ouyang S; Wang J; Huang Z; Wang J; Liao L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Oct; 33(5):529-33. PubMed ID: 26688950
[TBL] [Abstract][Full Text] [Related]
13. PD-1 and PD-L1 Expression on Circulating Lymphocytes as a Marker of Epstein-Barr Virus Reactivation-Associated Proliferative Glomerulonephritis.
Grywalska E; Smarz-Widelska I; Korona-Głowniak I; Mertowski S; Gosik K; Hymos A; Ludian J; Niedźwiedzka-Rystwej P; Roliński J; Załuska W
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33121190
[TBL] [Abstract][Full Text] [Related]
14. [Programmed death ligand 1 negatively regulates inflammatory response of chronic periodontitis].
Yuan W; Wang X; Zhang J; Zhou W; Feng Y; Chen J; Zhang P
Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Aug; 33(4):366-9. PubMed ID: 26552238
[TBL] [Abstract][Full Text] [Related]
15. [Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].
Li H; Liu Y; Liu Y; Liu J; Zhao D; Wang Y; Cheng Y
Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):755-760. PubMed ID: 29167005
[TBL] [Abstract][Full Text] [Related]
16. PD-1/PD-L1 pathway: A double-edged sword in periodontitis.
Liu X; Yang L; Tan X
Biomed Pharmacother; 2023 Mar; 159():114215. PubMed ID: 36630848
[TBL] [Abstract][Full Text] [Related]
17. PD-1/PD-L1 expression on CD(4+) T cells and myeloid DCs correlates with the immune pathogenesis of atrial fibrillation.
Liu L; Zheng Q; Lee J; Ma Z; Zhu Q; Wang Z
J Cell Mol Med; 2015 Jun; 19(6):1223-33. PubMed ID: 25810125
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.
Braun NA; Celada LJ; Herazo-Maya JD; Abraham S; Shaginurova G; Sevin CM; Grutters J; Culver DA; Dworski R; Sheller J; Massion PP; Polosukhin VV; Johnson JE; Kaminski N; Wilkes DS; Oswald-Richter KA; Drake WP
Am J Respir Crit Care Med; 2014 Sep; 190(5):560-71. PubMed ID: 25073001
[TBL] [Abstract][Full Text] [Related]
19. High programmed death 1 expression on T cells in aplastic anemia.
Zhao W; Zhang Y; Zhang P; Yang J; Zhang L; He A; Zhang W; Hideto T
Immunol Lett; 2017 Mar; 183():44-51. PubMed ID: 28153603
[TBL] [Abstract][Full Text] [Related]
20. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.
Jin S; Xu B; Yu L; Fu Y; Wu H; Fan X; Wei J; Liu B
Oncotarget; 2017 Jun; 8(24):38850-38862. PubMed ID: 28418918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]